Almost three-quarters of all marijuana purchased in California this year will be of the illicit variety.
News & Analysis: MedMen Enterprises Inc.
Two of these three states should be billion-dollar cannabis markets by 2024.
Well, that didn't take long -- the company's recently opened facility in Portugal is about to ship product. Meanwhile, MedMen comes up with its own delivery enhancement.
Here's a hint: The outlook for legalization looks quite sunny.
The dispensary operator also announced a new cannabis rewards program.
With up to 196% upside, should these cannabis stocks be in your portfolio?
Which stock wins in a matchup between a top cannabis retailer and the leading marijuana REIT?
Big names don't necessarily make for the best investments.
The small-cap healthcare stocks Catalyst Pharmaceuticals and MedMen Enterprises have enormous upside potential.
Aleafia Health and MedMen Enterprises are two penny pot stocks worth keeping tabs on.